[Commentary on] Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: Results of a North American trial Journal Article

  


Authors: Mills, N. E.; Wasserheit, C.
Article Title: [Commentary on] Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: Results of a North American trial
Keywords: disease progression; postmenopause; north america; antineoplastic agents -- therapeutic use; breast neoplasms -- drug therapy; antineoplastic agents -- adverse effects; random assignment; female; endocrine system -- drug effects
Journal Title: Women's Oncology Review
Volume: 2
Issue: 4
ISSN: 1473-3404
Publisher: Taylor & Francis Group  
Date Published: 2002-12-01
Start Page: 441
End Page: 442
Language: English
ACCESSION: 2004138641
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:

http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=2004138641&site=ehost-live
Notes: Accession Number: 2004138641 -- Entry Date: 20040820 -- Revision Date: 20090313 -- Publication Type: journal article; abstract; commentary -- Original Study: Osborne CK, Pippen J, Jones SE, Parker LM, Ellis M, Come S et al -- Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial -- J CLIN ONCOL 2002; 20: 3386-95 -- Journal Subset: Biomedical; Editorial Board Reviewed; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 101128014. -- Source: cin20